HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
Abstract Background RUNX2 is a Runt-related transcription factor required during embryogenesis for skeletal development and morphogenesis of other organs including thyroid and breast gland. Consistent evidence indicates that RUNX2 expression is aberrantly reactivated in cancer and supports tumor pro...
Main Authors: | Gloria Manzotti, Federica Torricelli, Benedetta Donati, Valentina Sancisi, Mila Gugnoni, Alessia Ciarrocchi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1350-5 |
Similar Items
-
Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy
by: Gloria Manzotti, et al.
Published: (2019-03-01) -
Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6
by: G. R. Vanaja, et al.
Published: (2018-05-01) -
The Role of Runx2 in Microtubule Acetylation in Bone Metastatic Breast Cancer Cells
by: Ahmad Othman, et al.
Published: (2022-07-01) -
The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention
by: Rahma K. Alseksek, et al.
Published: (2022-07-01) -
Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
by: Elizabeth A. Thomas
Published: (2014-05-01)